Uterine cancer
MONDO:0002715Primary or metastatic malignant neoplasm involving the uterine corpus and/or the cervix.
Also known as: neoplasm of uterus, tumor of uterus, tumour of uterus, uterine tumor, uterine tumour, uterus neoplasm, cancer of the uterus, cancer of uterus
3990 clinical trials for this condition and its sub-types, 96 tagged with Uterine cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Uterine cancer
-
Cervical cancer 576 trials · 700 incl. sub-types
9 sub-types
- Cervical carcinoma 257 trials · 317 incl. sub-types Sub-types →
- High-grade neuroendocrine carcinoma of the cervix uteri 4 trials
- Malignant neoplasm of endocervix 0 trials · 4 incl. sub-types Sub-types →
- Cervix melanoma 1 trial
- Malignant mixed epithelial and mesenchymal tumor of cervix uteri 0 trials · 1 incl. sub-types Sub-types →
- Cervical Wilms tumor 0 trials
- Malignant germ cell tumor of cervix uteri 0 trials
- Sarcoma of cervix uteri 0 trials Sub-types →
- Uterine ligament cancer 0 trials Sub-types →
-
Endometrial cancer 458 trials · 650 incl. sub-types
2 sub-types
- Endometrial carcinoma 209 trials · 316 incl. sub-types Sub-types →
- Endometrioid stromal sarcoma 2 trials Sub-types →
-
Uterine carcinoma 3 trials · 614 incl. sub-types
9 sub-types
- Cervical carcinoma 257 trials · 317 incl. sub-types Sub-types →
- Endometrial carcinoma 209 trials · 316 incl. sub-types Sub-types →
- Endometrial serous adenocarcinoma 36 trials
- Uterus carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Adenoid cystic carcinoma of the corpus uteri 0 trials
- Papillary carcinoma of the corpus uteri 0 trials
- Squamous cell carcinoma of the corpus uteri 0 trials
- Transitional cell carcinoma of the corpus uteri 0 trials
- Undifferentiated carcinoma of the corpus uteri 0 trials
-
Uterine corpus cancer 33 trials · 85 incl. sub-types
12 sub-types
- Endometrial serous adenocarcinoma 36 trials
- Uterine corpus sarcoma 12 trials · 19 incl. sub-types Sub-types →
- Uterine body mixed cancer 0 trials · 14 incl. sub-types Sub-types →
- Adenoid cystic carcinoma of the corpus uteri 0 trials
- High-grade neuroendocrine carcinoma of the corpus uteri 0 trials
- Low-grade neuroendocrine tumor of the corpus uteri 0 trials
- Malignant germ cell tumor of corpus uteri 0 trials Sub-types →
- Papillary carcinoma of the corpus uteri 0 trials
- Squamous cell carcinoma of the corpus uteri 0 trials
- Transitional cell carcinoma of the corpus uteri 0 trials
- Undifferentiated carcinoma of the corpus uteri 0 trials
- Uterine corpus endometrial carcinoma 0 trials
-
Uterine carcinosarcoma 23 trials · 32 incl. sub-types
2 sub-types
- Carcinosarcoma of the corpus uteri 13 trials
- Cervical carcinosarcoma 0 trials
-
Placenta cancer 0 trials · 1 incl. sub-types
1 sub-type
- Placental choriocarcinoma 1 trial
-
Uterine adnexa cancer 0 trials
2 sub-types
- Broad ligament malignant neoplasm 0 trials Sub-types →
- Round ligament malignant neoplasm 0 trials
Most studied deeper sub-types
-
Can a new antibody help the immune system fight Hard-to-Treat tumors?
Disease control CompletedThis trial tests an experimental drug called SNS-101, which targets a protein called VISTA that may help tumors evade the immune system. Researchers give SNS-101 alone or with another immunotherapy, cemiplimab, to adults with advanced solid tumors that have not responded to stand…
Phase 1/2 • Sponsor: Sensei Biotherapeutics, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a targeted drug shrink recurrent endometrial tumors?
Disease control CompletedThis phase II trial tests whether the drug RAD001 can shrink or slow the growth of tumors in people with recurrent endometrial cancer. Participants take RAD001 daily by mouth. The study measures how many patients have their tumors shrink or stay stable, and also tracks side effec…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug combo takes on advanced cancers in early trial
Disease control CompletedThis early-phase trial tested an experimental drug called KVA12123, given alone or with the immunotherapy Keytruda, in 40 adults with advanced solid tumors (like lung, breast, or colon cancer) that had stopped responding to standard treatments. The main goals were to check safety…
Phase 1/2 • Sponsor: Kineta Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to keep endometrial cancer at bay after chemo
Disease control CompletedThis Phase 3 trial tested whether taking the drug selinexor as a maintenance pill after chemotherapy can help delay cancer progression in people with advanced or recurrent endometrial cancer. 263 participants who had responded to initial chemo were randomly assigned to receive ei…
Phase 3 • Sponsor: Karyopharm Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New Tamoxifen-Like drug tested for stubborn hormone cancers
Disease control CompletedThis early-stage trial tested an experimental drug called Z-Endoxifen in 40 adults with hormone receptor-positive cancers (like breast, ovarian, or desmoid tumors) that had stopped responding to standard treatments. Z-Endoxifen is a direct form of tamoxifen's active ingredient, b…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can brain training ease 'Chemo Brain' in gynecologic cancer survivors?
Symptom relief CompletedThis study tested a home-based cognitive training program called BrainHQ in 60 women with gynecologic cancers who had memory or thinking problems after chemotherapy. Participants used the app for about 2.5 hours per week for 10 weeks. The goal was to see if the program was practi…
Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Can pelvic PT help cancer survivors regain sexual health?
Symptom relief CompletedThis study looked at whether a 10-week pelvic physical therapy program is practical for gynecologic cancer survivors who have sexual problems. Twenty survivors were enrolled to see if they could stick with the program and if it improved their sexual function and quality of life. …
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Phone therapy eases cancer Survivors' distress in rural areas
Symptom relief CompletedThis study tested a stepped-care telehealth program for cancer survivors living in rural areas who experience anxiety, depression, or sleep problems. Participants received either low-intensity check-ins or high-intensity phone therapy with a licensed therapist, depending on sympt…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Talking through cancer: can couples therapy ease the emotional toll?
Symptom relief CompletedThis study tested a program that teaches couples communication skills when one partner has advanced cancer. About 440 patients and their partners took part, with half receiving the training and half getting general healthy living information. The goal was to see if the training c…
Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Nerve block may cut opioid needs after hysterectomy
Symptom relief CompletedThis study tested whether a nerve block called the anterior quadratus lumborum block, given before surgery, can reduce pain and the need for opioids in women undergoing abdominal hysterectomy. 56 participants were randomly assigned to receive either the nerve block plus standard …
Sponsor: Yuri Semenyuk Rivne Regional Clinical Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Can a short video ease anxiety for cancer patients facing radiation?
Symptom relief CompletedThis study tested whether an educational video about brachytherapy (a type of internal radiation) helps women with cervical or uterine cancer feel more satisfied and less anxious. Eighty patients were randomly assigned to watch the video or receive standard consent only. Research…
Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Can a smartphone app and fitbit ease cancer treatment? new study says maybe.
Symptom relief CompletedThis study tested whether a smartphone app (HOPE or SMART) paired with a Fitbit could help women with recurrent gynecologic cancer manage symptoms and improve quality of life during chemotherapy. 102 women participated, using the app to track symptoms and receive advice, while we…
Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 26, 2026 14:54 UTC
-
Study probes how pelvic cancer strains Couples' intimacy
Knowledge-focused CompletedThis study followed 40 women with cervical, uterine, or ovarian cancer to see how their relationship and sexual communication changed from diagnosis to 3 months after treatment. Participants filled out questionnaires about their sexual activity, desire, and discomfort. The goal w…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Robot vs. standard surgery: which is safer for Women's cancers?
Knowledge-focused CompletedThis study looked at 386 women with cervical, uterine, or ovarian cancer to compare standard laparoscopic surgery versus robot-assisted laparoscopic surgery. The goal was to see which approach causes fewer complications within six months after the operation. Researchers tracked s…
Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Study reveals metabolic changes in gynecologic cancer patients after treatment
Knowledge-focused CompletedThis study looked at how a single round of chemotherapy or immunotherapy changes the way the body uses energy and fats in women with gynecologic cancers. Researchers measured breathing and blood markers in 43 participants before and after treatment. The goal was to learn more abo…
Sponsor: University of Tennessee Graduate School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Can a lifestyle program help endometrial cancer survivors stay healthier?
Knowledge-focused CompletedThis study tested a group-based program to help endometrial cancer survivors adopt healthier habits. The goal was to lower their risk of other health problems like heart disease and diabetes. Twenty-three survivors who had finished cancer treatment took part in online learning an…
Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New dye technique may help surgeons spot hidden cancer spread
Knowledge-focused CompletedThis study tested a modified method for injecting a green dye (indocyanine green) to help surgeons see lymph nodes during robotic surgery for early-stage endometrial cancer. The new approach injects the dye until the lymphatic channels are visible in real time, aiming to improve …
Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC